IL‐6 via the inflammation pathway has a strong effect in all organs, and other studies have similar findings and have shown an association between increased IL‐6 with an increased risk of arrhythmia in COVID‐19 patients (Hami et al., 2009; Jirak et al., 2021; Qian et al., 2022; Wang et al., 2021). The gene discussed is IL6; the disease is cardiac arrhythmia.